What is the recommended maintenance target for the Richmond Agitation‑Sedation Scale (RASS) in an adult intubated patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Recommended RASS Target for Intubated Patients

The recommended maintenance target for RASS in adult intubated patients is -2 to 0 (light sedation to awake and calm), with the goal that patients can purposely follow commands without agitation. 1

Evidence-Based Sedation Targets

The 2013 Critical Care Medicine PAD Guidelines establish clear sedation targets based on robust evidence showing that lighter sedation improves clinical outcomes 1:

  • Target RASS: -2 to 0 (equivalent to SAS 3-4)
  • Goal: Patient purposely follows commands without agitation
  • Assessment frequency: At least 4 times per shift and as needed

RASS Score Definitions

  • RASS 0: Awake and calm
  • RASS -1 to -2: Lightly sedated (drowsy but arousable)
  • RASS -3 to -5: Deeply sedated (over-sedated range to avoid)
  • RASS +1 to +4: Agitated (under-sedated)

Clinical Management Algorithm

If Patient is Over-Sedated (RASS < -2):

  1. Hold sedatives immediately until patient reaches target range
  2. Restart at 50% of previous dose once at target 1

If Patient is Under-Sedated (RASS > 0):

  1. Assess and treat pain first using validated pain scales (BPS or CPOT)
  2. Use non-benzodiazepine sedatives preferentially (propofol or dexmedetomidine)
  3. Exception: Use benzodiazepines only for alcohol or benzodiazepine withdrawal 1

Supporting Evidence for Light Sedation

Maintaining lighter sedation levels is associated with improved outcomes 1:

  • Reduced duration of mechanical ventilation
  • Shorter ICU length of stay
  • Lower mortality rates
  • Decreased incidence and duration of delirium

Recent 2024 BMJ guidelines confirm this approach, noting that trials comparing light sedation strategies (RASS 0 to -3) demonstrate superior outcomes compared to deep sedation 2, 3.

Special Circumstances Requiring Deeper Sedation

Deeper sedation (RASS -3 to -5) may be necessary for:

  • Severe ARDS requiring lung-protective ventilation or prone positioning 3
  • Patients receiving neuromuscular blocking agents (use brain function monitoring as adjunct) 1
  • Elevated intracranial pressure requiring burst suppression 1

Implementation Strategy

Use a sedation protocol with daily sedation interruption or continuous light sedation targeting 1:

  • Treat pain first, then sedate (analgesia-first approach) 1
  • Use RASS or SAS as the validated assessment tool 1
  • Document sedation assessments at least 4 times per shift 1
  • Avoid routine deep sedation unless clinically indicated

Common Pitfalls to Avoid

  • Do not use vital signs alone to assess sedation adequacy 1
  • Do not routinely use benzodiazepines for sedation (associated with increased delirium) 1
  • Do not maintain deep sedation (RASS < -2) without specific clinical indication 1
  • Do not forget to assess pain before escalating sedation for agitation 1

Research demonstrates that implementing RASS-guided protocols reduces ventilator days by 31% and decreases ICU length of stay 4, with patients achieving goal RASS scores 44% of the time post-implementation versus 31% pre-implementation 5.

References

Related Questions

What is the recommended sedation strategy for adult ICU patients, including an analgesia‑first approach, appropriate drug selection, dosing, and monitoring parameters?
How is a patient's treatment plan adjusted based on their Richmond Agitation-Sedation Scale (RASS) score?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
What does a tremor that disappears on the finger-to-nose test indicate?
Which ICD‑10‑CM diagnosis code(s) should be used to bill a Comprehensive Management/Medication Review (CMP) service under Medicare?
What are the Indian Academy of Pediatrics (IAP) versus American Academy of Pediatrics (AAP) recommendations for the evaluation and management of an infant with antenatally detected hydronephrosis?
What is the difference between the 125 µg and 250 µg doses of Flixotide (fluticasone propionate) inhaler?
In Gradenigo syndrome, will the cranial nerve (abducens) palsy resolve completely with appropriate intravenous antibiotic therapy, or can it leave residual deficits?
What are the bulbocavernosus reflex and the anal reflex?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.